NASDAQ:SLDB - Solid Biosciences Price Target & Analyst Ratings

Sign in or create an account to add this stock to your watchlist.
$8.96 +0.46 (+5.41 %)
(As of 02/22/2019 04:00 PM ET)
Previous Close$8.96
Today's Range$8.50 - $9.12
52-Week Range$5.97 - $54.84
Volume1.06 million shs
Average Volume1.62 million shs
Market Capitalization$317.45 million
P/E RatioN/A
Dividend YieldN/A

Analyst Ratings

Solid Biosciences (NASDAQ:SLDB) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
8 Wall Street analysts have issued ratings and price targets for Solid Biosciences in the last 12 months. Their average twelve-month price target is $32.6667, suggesting that the stock has a possible upside of 264.58%. The high price target for SLDB is $57.00 and the low price target for SLDB is $8.00. There are currently 1 sell rating, 5 hold ratings and 2 buy ratings for the stock, resulting in a consensus rating of "Hold."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: HoldHoldHoldBuy
Consensus Rating Score:
Ratings Breakdown: 1 Sell Rating(s)
5 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
2 Sell Rating(s)
3 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
2 Sell Rating(s)
2 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
1 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $32.6667$43.3750$42.6250$46.3333
Price Target Upside: 264.58% upside68.84% upside23.77% upside7.38% upside

Solid Biosciences (NASDAQ:SLDB) Consensus Price Target History

Price Target History for Solid Biosciences (NASDAQ:SLDB)

Solid Biosciences (NASDAQ:SLDB) Analyst Ratings History

DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
2/8/2019Svb LeerinkDowngradeOutperform ➝ Market PerformLowView Rating Details
2/8/2019CitigroupUpgradeSell ➝ Neutral$8.00MediumView Rating Details
2/7/2019Leerink SwannDowngradeOutperform ➝ Market PerformHighView Rating Details
2/7/2019Chardan CapitalReiterated RatingBuy$15.00HighView Rating Details
12/10/2018BTIG ResearchInitiated CoverageNeutralLowView Rating Details
9/6/2018Credit Suisse GroupInitiated CoverageNeutral ➝ Neutral$38.00HighView Rating Details
6/25/2018NomuraBoost Price TargetBuy$37.00 ➝ $57.00HighView Rating Details
3/15/2018JPMorgan Chase & Co.DowngradeNeutral ➝ Underweight$28.00HighView Rating Details
2/20/2018InstinetInitiated CoverageBuy$52.00HighView Rating Details
2/20/2018Goldman Sachs GroupInitiated CoverageNeutral$31.00HighView Rating Details
(Data available from 2/23/2017 forward)
This page was last updated on 2/23/2019 by Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.

Yahoo Gemini Pixel